Evidence map›Paper›PMID 26879192›Full record

ArticleLangenbeck's archives of surgery2016

Lymph node hypoplasia is associated with adverse outcomes in node-negative colon cancer using advanced lymph node dissection methods.

Patrick Mayr, Georg Aumann, Tina Schaller, Gerhard Schenkirsch, Matthias Anthuber, Bruno Märkl

Abstract read
PubMed Publisher
In one paragraph

Article in Langenbeck's archives of surgery, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Preoperative assessment of lymph node metastasis in Colon Cancer patients using machine learning: a pilot study.Cancer imaging : the official publication of the International Cancer Imaging Society · 2020
    Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Observational
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Patrick MayrInstitute of Pathology, Zentralklinikum Augsburg, Stenglinstrasse 2, 86156, Augsburg, Germany.
Georg AumannDepartment of Visceral and Transplantation Surgery, Klinikum Augsburg, Augsburg, Germany.
Tina SchallerInstitute of Pathology, Zentralklinikum Augsburg, Stenglinstrasse 2, 86156, Augsburg, Germany.
Gerhard SchenkirschClinical and Population-Based Cancer Registry of Augsburg, Klinikum Augsburg, Augsburg, Germany.
Matthias AnthuberDepartment of Visceral and Transplantation Surgery, Klinikum Augsburg, Augsburg, Germany.
Bruno MärklInstitute of Pathology, Zentralklinikum Augsburg, Stenglinstrasse 2, 86156, Augsburg, Germany. bruno.maerkl@klinikum-augsburg.de.
University Hospital Augsburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeLymph node size as a prognostic parameter has not been investigated well in the past. Recent data, however, have indicated that this parameter could be even more important than the lymph node count.

methodsBased on the results of earlier studies, we analyzed the lymph node size and number of node-negative colon cancer patients with regard to survival. Data from 115 node-negative cases of colon cancer were analyzed. Lymph nodes with diameters ≤5 mm were defined as small, and all other lymph nodes were classified as intermediate/large in size and labeled LN5. All of the cases were categorized according to the number of LN5s. The LN5 very low (LN5vl) group included cases with less than two LN5s. All of the other cases were assigned to the LN5 low/high (LN5l/h) group.

resultsThe overall survival analysis revealed significantly worse outcomes for the LN5vl group, with a mean survival of 34 months compared to the LN5l/h group, with a mean survival of 40 months (P = 0.022). After adjusting for the pT1/2 and pT3/4 stages, we still found a significant outcome difference (P = 0.012). Multivariate analysis identified LN5vl and T-stage as being independently correlated with the outcome. The vast majority of LN5vl cases (91 %) were located in the left colon. The location itself, however, was not prognostic (P = 0.478).

conclusionLN5 count, as a marker of immune response, could be shown as being prognostic in node-negative colon cancer. Patients with low LN5 counts showed poor outcomes. These patients could perhaps profit from adjuvant chemotherapy.

Indexed as

Lymph Node ExcisionAgedAged, 80 and overCohort StudiesColonic NeoplasmsFemaleHumansLymph NodesMaleMethylene BlueMiddle AgedNeoplasm InvasivenessReproducibility of ResultsSurvival AnalysisSurvival RateMethylene BlueColon cancerHyperplasiaHypoplasiaLymph node sizeStage migration

Identifiers

PMID26879192
OpenAlexW2287228898

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.